Finns choose a domestic nicotine-free product as their preferred smoking intervention method
Biohit Oyj and Sanoma Media invited 40 volunteers to try and quit smoking by using Acetium® lozenge and asked for feedback on their experience of using this alternative method. They received encouraging and positive comments from the users and with the help of Acetium, 93% of the test group reduced smoking significantly or quit smoking completely during the two months of testing.
Based on the test group, most people trying to quit smoking are concerned about their health and want to put an end to unnecessary spending. 89% of the test group felt that Acetium® lozenge being nicotine-free was rather, or, very important. In addition, 96% of the test group felt that the product being domestic in origin was important. Yet the market is dominated by foreign products that contain nicotine. When quitting smoking, consumers have been steered towards using nicotine or other tobacco products, such as snus.
People most often buy their intervention product from a grocery store where guidance about its use or advice about the pros/cons is not available. There is more guidance available when buying the product in a pharmacy. Switching to a nicotine replacement product is therefore a familiar and learned habit that leads most people to long-term nicotine dependence.
Examples from the test group’s experiences:
“Cutting down happened after just a couple of days use because cigarettes started to taste bad.” Ilkka, 35 years.
“Easy to use. I’m going to get my spouse to use it, too.” Mirva, 38 years.
“New and different, and no need to use nicotine if that’s the problem.” Sam, 43 years.
“An awesome product, doesn’t irritate the stomach and tastes pleasant. Definitely the healthiest alternative among smoking intervention products.” Marko, 25 years.
“Doesn’t contain nicotine, the blister-pack is easy to slide into a pocket, and the package doesn’t take up a lot of space in the bag and seems to work.” Milla, 32 years.
“I realized rather quickly that tobacco had lost its taste completely. I didn’t believe the slogan at first, that one day you’ll notice you have forgotten smoking. The slogan was right all along. I’d never have believed it. I’m slowly bidding farewell to tobacco, and Acetium has really helped. My colleagues have shown interest in this product, so I’m definitely going to recommend it to others!” Susanna, 42 years.
“My craving for cigarettes during the workday disappeared, so I wouldn’t go outside like I did before. It was harder to give up the moments of stress-relief. However, I seemed to lose the actual craving and need for nicotine.” Niina, 36 years.
Nearly 80 % of the test group felt that Acetium® lozenge, a product of Finland, tastes good and 85 % felt it is easy to use.
Source: Sanoma Media Finland test group January to March 2019. N=29
Acetium® lozenge was launched for retail in September 2018 and is now widely available across the country. The product is on sale in pharmacies, Kesko markets, Lidl, R-kiosks, natural food stores with extensive selections, and in Tokmanni, Kärkkäinen, Minimani and Halpahalli chains. In January 2019, the S Group, specifically the Prisma markets, put it on their shelves.
Acetium is easy and safe to use. The product has not been categorized a pharmaceutical, and it is sold over the counter. Using it regularly while smoking for 3 to 6 months will provide the best result. With some people, good results can be achieved in just a few weeks.
Studies prove that Acetium works
The effect of Acetium® lozenge on quitting smoking has been researched in two clinical studies 1, 2. Its regular use in connection with smoking increased the probability of quitting by 1.5 compared to placebo 2. The effectiveness compares to nicotine replacement products.
For more information please contact:
CEO Semi Korpela, Biohit Oyj
Tel. +358 9 773 861
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is "Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the United Kingdom. Biohit’s series B share (BIOBV) is quoted on NASDAQ OMX Helsinki, Small cap/Healthcare. www.biohit.fi
1. Syrjänen K et al. Elimination of cigarette smoke-derived acetaldehyde in saliva by slow-release L-cysteine lozenge is an effective new method to assist smoking cessation. A randomised, double-blind, placebo-controlled intervention. Anticancer Res. 2016;36:2297-2306.
2. Syrjänen K et al. Slow-release L-cysteine (Acetium) lozenge is an effective new method in smoking cessation. A randomized, double-blind, placebo-controlled intervention. Anticancer Res 2017;37:3639-3648.
3. Salaspuro VJ et al. Eliminating carcinogenic acetaldehyde by cysteine from saliva during smoking. Cancer Epid Biomark Prev 2006;15:146-149.
4. Secretan B et al. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens- Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10:1033-1034.
Upcoming Life Sciences Events
- September 2019
- Boston: 9th Annual American Drug Delivery & Formulation Summit
- Malmo: NLS Days 2019
- Boston: Redefining Early Stage Investments (RESI)
Latest company news
There are currently no news available for this portal